Almac says its first leap into Next Generation Sequencing (NGS) data analysis services is a much needed-change from the industry’s current “one-size-fits-all” offering.
A patent loss-fuelled surge in big pharma outsourcing will push the European CMO market through the $20bn barrier by 2018, analysis claims.
Greater collaboration between regulators, suppliers and manufacturers is needed to reverse decades of supply chain neglect, an expert said.
Charles River wants to buy drug discovery assets to meet interest in strategic outsourcing of non-regulated efficacy testing.
ATMI launches large-volume bioreactor with GMP compliance in mind
Large volume production is a must for the cell therapy sector according to ATMI, which claims the latest addition to its single-use bioreactor range can help manufacturers overcome the GMP hurdles that hinder commercial scale-up.
CROs still seen as good investment says leading banker
The CRO industry is still considered a good long-term investment and the clinical services segment is set to continue its dominance thanks to sponsor R&D spending, says leading banker.
3M launches advanced filtration system for biotech market
3M, the US-headquartered multinational, has launched a new range of bio filters which it says raise the benchmarks for flow-rate, organism reduction and efficiency across a range of applications.
Batavia gains bioprocessing assets in Xendo collaboration
Batavia Bioservices has gained access to simulated moving bed (SMB) technology by collaborating with Xendo.
Tamper evident devices must be traceable & unique; Rx-360
Physical endurance, traceability and uniqueness are key characteristics for tamper evident devices used in raw material supply, according to Rx-360.
EMD opens Shanghai biopharma training plant
EMD Millipore has opened a training facility in China as an education resource for the country’s rapidly expanding biopharmaceutical manufacturing and development sector.
The biomanufacturing industry needs to adopt an integrated approach to upstream and downstream processing to boost efficiency and productivity according to EMD Millipore.
Sharp enters TraceLink Network to become services “concierge”
Sharp Corporation has joined the TraceLink Network to provide production visibility and serialisation services for life sciences customers.
ATMI acquires Artelis in ‘disposables’ deal
ATMI has acquired Artelis, a Belgian biotech firm, in an effort to “get closer to customers” by widening its disposable technology portfolio to the life sciences research and manufacturing sector.
RXi and EyeGate’s needle-free ocular RNAi delivery: Part 2
RXi and EyeGate lift the lid on ocular delivery of RNAi therapeutics for retinal disorders as the two firm’s team up to provide a unique needle-free solution.
Taxol precursors produced in engineered E coli
Cost-effective, large-scale production of oncology drug Taxol (paclitaxel) intermediates could eventually be achieved using engineered Escherichia coli.
iBio, GE partner to work on plant-based production tech
iBio, CMB and GE Healthcare are collaborating on developing and marketing biopharm production systems, including plant-based expression technology.
Celleuxs launches “broad cell line” disposable bioreactor
Cellexus has expanded its disposable bioreactor offering with a unit designed to give biomanufacturers greater flexibility in their choice of cell lines.
Pall and New Brunswick partner on disposable bioreactors
Pall and New Brunswick have teamed up to develop and supply new disposable bioreactor technologies, targeting growing demand for products that improve quality and reduce cost of biomanufacturing.
Charles River Laboratories (CRL) is to acquire WuXi PharmaTech for $1.6bn (€1.2bn), creating a global CRO capable of offering fully integrated services from molecule creation to first-in-human testing.
ATMI introduces disposable bioreactor
ATMI is using Interphex 2010 to launch the Integrity PadReactor, a disposable bioreactor designed to provide a highly scalable entry point in its line of mixing and process manufacturing systems.
Eden Biodesign and Millipore partner on cell line tech
Access to Millipore’s UCOE expression technology though a new partnership is “step change” for customers, says contract manufacturing organization (CMO) Eden Biodesign.
Sartorius launches single-use biomanufacturing range
Sartorius Stedim Biotech has introduced FlexAct BP, the first product in a range which will be an integrated single-use system for entire biomanufacturing steps in upstream and downstream processing.
Millipore rolls out CellReady 3L benchtop bioreactor
Millipore has expanded its Mobius process technology range with the new CellReady 3L bench-top bioreactor.
Avid’s revenues rise 74%; discusses expansion plans
CMO Avid Bioservices’ revenues rose by 74 per cent to $2.1m (€1.5m) in Q2, generating a further $7m from its parent company, and it has plans to boost output and become a leader in mammalian cell culture production.
Novasep buys to get big in bio
Novasep has bolstered its upstream processing capabilities by acquiring Henogen, a Belgium-based CMO that has biotech development and cGMP manufacturing expertise.
US CMOs economy proof in the long term, says F&S
The US contract manufacturing sector is strong enough to bounce back from any short-term slow down caused by the credit crisis, according to a new report by Frost & Sullivan (F&S).
Alliance launches animal-free culture supplement
Novozymes and Millipore have launched an animal-free culture supplement, which has been designed to reduce risk and regulatory pressures in upstream biopharmaceutical processes.
Pall hopes to have manufacturing in the bag
Pall Life Sciences has launched its Allegro 3D biocontainers, which have been designed to improve the performance of the company’s large-scale, single use manufacturing systems.
SSB signs deal for virus clearance tech
Sartorius Stedim Biotech (SSB) and Bayer Technology Services (BTS) have signed an exclusive cooperation agreement for the manufacture and marketing of UVivatec products.
Piramal expands contract services and research
India-based Piramal Healthcare has extended the range of early phase drug product development and manufacturing on offer at its Morpeth, UK facility.
Pharma manufacturing: People on the move
in-PharmaTechnologist.com presents its latest round-up of personnel changes in the pharmaceutical manufacturing sector.
Pharma manufacturing products: News in brief
in-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from Premier Pneumatics, GE Healthcare and WaterSep.
Agilent and Millipore join forces to further epigenetics research
Agilent and Millipore have formed a collaboration to develop fully validated chromatin immunoprecipitation (ChIP) microarray kits that will improve productivity and streamline epigenetic analysis.
PER.C6 platform achieves highest ever yield
The PER.C6 cell culture-based antibody production platform has
achieved a new record yield of 27 grams of IgG antibody per litre,
bettering the 15 gram per litre mark that was reported earlier in
Europe to witness biopharma capacity jump
Europe is tipped to witness the most significant worldwide gains in
biopharmaceutical manufacturing production capacity in the coming
years, despite an overall global decline in capacity utilisation by
Bosch makes liquid filling a disposable option
The use of disposable manufacturing equipment in pharmaceutical
production and greater need for containment equipment were
recurring themes at the Interphex show in Philadelphia last week,
and both were addressed by new equipment...
Syft says new instrument is 'new generation' of SIFT-MS
Syft Technologies of New Zealand released the latest generation of
Selected Ion Flow Tube-Mass Spectrometry (SIFT) instrumentation at
Pittcon 2008 for the analysis of very low levels of organic
compounds in air (detection limits as...
California gives industry a two-year reprieve on ePedigree
Pharmaceutical manufacturers, distributors and retailers alike have
welcomed a unanimous vote by the California State Board of Pharmacy
to delay for another two years the implementation of electronic
pedigree requirements for tracking...
Improved gene expression accelerates biologic drug production
Bayer Healthcare is to deploy a new technique, developed by
Millipore, for genetically engineering cells to produce
pharmaceutically useful proteins that could both increase the yield
and accelerate drug production.
Artel MVS add-on ups QC for liquid handing
Artel has introduced a new feature for its Multichannel
Verification System (MVS), which includes an automation function
that allows for time savings and reducing human error.
Cellexus extends rental plan for disposable bioreactor
Cellexus Biosystems, the UK company that designs, manufactures and
sells disposable cell growth technology for the biopharmaceutical
industry, is extending the rental plan offered on its CellMaker
Lite2 single-use bioreactor in response...
Novozymes and Millipore to supply cell culture supplements
Novozymes and Millipore are to supply animal-free cell
culture supplements to the biopharmaceutical industry.
Indian firm takes over German biologics plant
An Indian firm has taken over the contract biologics manufacturing
business of German corporation Siegfried.
GE Healthcare introduces new bioprocessing products
UK-based GE Healthcare is introducing nine new product lines for
SolVin to increase PVDC production
SolVin is to expand its polyvinylidene chloride (PVDC) latex
manufacturing site in Tavaux, France, in a bid to meet growing
demand for the packaging material.
Baxter recalls more infusion pumps
Baxter Healthcare remains in murky waters in regard to its infusion
pumps after announcing yesterday it would be recalling an
additional 986 of its Colleague brand pumps.
Procter & Gamble looking to outsource API work
Procter & Gamble (P&G) has announced its intention to
outsource the active pharmaceutical ingredient (API) R&D and
manufacturing work undertaken at one of its US factories, with
resultant closure of the site and job losses.
Hunting for drug candidates on Kinase SARfari
BioFocus DPI has released a new informatics system that can combine
chemical and biological data from various sources to optimise
protein kinase inhibitor candidate selection.
The most innovative drugs from cancer expo
This year's American Society for Clinical Oncology (ASCO)
conference is over and as 45,000 scientists head home,
DrugResearcher.com looks at some of the most innovative drugs that
were on show.
Thermo and Sartorius sign disposables agreement
Thermo Fisher Scientific and Sartorius have signed a supply
agreement continuing the relationship between Sartorius and
Thermo's recently acquired TC Tech.